Advertisement

Extended H5N1 Moratorium?

A US science official recommends extending moratorium on bird flu studies as well as other types of risky research.

By | April 30, 2012

image: Extended H5N1 Moratorium? Two avian influenza A (H5N1) virionsWikimedia Commons, Cynthia Goldsmith/Jackie Katz

Two avian influenza A (H5N1) virionsWIKIMEDIA COMMONS, CYNTHIA GOLDSMITH/JACKIE KATZ

Despite positive recommendations by the National Science Advisory Board for Biosecurity (NSABB) and the US Department of Health and Human Services to publish in full the results of two H5N1 studies that managed to make the virus transmissible between ferrets, the director of the National Institute of Allergy and Infectious Diseases (NIAID) Anthony Fauci and others recommended that researchers respect "an extension on the moratorium" on such dual use research, ScienceInsider reported.

"The question is for how long," Fauci said while addressing a US Senate Committee on Homeland Security and Governmental Affairs last week.

The original 60-day voluntary moratorium on H5N1 transmissibility research was initiated by a letter signed by 39 influenza researchers on January 20, and was then extended by a World Health Organization (WHO) expert panel in February after it recommended the researchers publish the results in full. The WHO extension was intended to allow experts around the world to address the biosecurity concerns about the research, as well as to convey to the public the nature and importance of the studies before publication.

Indeed, much discussion has ensued during the now 4-month long moratorium. The US government instituted a new policy regard the review of dual use research, the National Science Advisory Board for Biosecurity and the US Department of Health and Human Services have recommended that the results of two H5N1 studies be published in full, and, just last Friday (April 27), the Dutch government announced that it will grant virologist Ron Fouchier of Erasmus MC an export license for his H5N1 transmissibility study, allowing him to submit a revised manuscript of his Science paper and finalize its publication without facing the threat of 6 years in prison or a $102,000 fine. But Fauci and others feel that there is more to be done before allowing such research to continue in full swing.

“Although this particular issue appears to have been resolved, it's going to recur and we can't just 'kick this can down the road' and deal with it on an ad hoc basis when it happens again," Senator Joseph Lieberman, who chaired the panel, said at the hearing.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Edward R. Mikol

Edward R. Mikol

Posts: 1457

April 30, 2012

Jeez- what a concept!  Trying to regulate the Suigenocide of the human species by its so-called "brightest" minds in the biotech field?

If terrorists can't have unfettered access to the potentially pandemic results of "pure science", then we all lose, right?

We must be prepared to die en masse to be show we have truly free inquiry!

It's called the Monty Python Theory of Longevity.

Avatar of:

Posts: 0

April 30, 2012

Jeez- what a concept!  Trying to regulate the Suigenocide of the human species by its so-called "brightest" minds in the biotech field?

If terrorists can't have unfettered access to the potentially pandemic results of "pure science", then we all lose, right?

We must be prepared to die en masse to be show we have truly free inquiry!

It's called the Monty Python Theory of Longevity.

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
NuAire Inc.
NuAire Inc.
Advertisement
NeuroScientistNews
NeuroScientistNews